Five global private equity firms, including Warburg Pincus, Permira, EQT, Bain, and TPG, are interested in bidding for Bharat Serums and Vaccines (BSV), which is seeking over $1 billion. The firms will sign expressions of interest soon and start due diligence on the Mumbai-based biopharmaceutical company. Advent International, the current owner, acquired BSV in 2019 and now wants to sell it. Some contenders may partner with pharmaceutical companies for the bid. Advent has engaged Jefferies and JP Morgan for the sale process.
Advisory Alpha LLC increased its holdings in shares of Vanguard Short-Term Bond ETF (NYSEARCA:BSV – Free Report) by 2.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,451 shares of the company’s stock after purchasing an additional 440 […]
Advisory Alpha LLC grew its position in shares of Vanguard Short-Term Bond ETF (NYSEARCA:BSV – Free Report) by 2.1% during the fourth quarter, HoldingsChannel reports. The firm owned 21,451 shares of the company’s stock after buying an additional 440 shares during the period. Advisory Alpha LLC’s holdings in Vanguard Short-Term Bond ETF were worth $1,652,000 […]
Cahaba Wealth Management Inc. grew its holdings in Vanguard Short-Term Bond ETF (NYSEARCA:BSV – Free Report) by 126.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,208 shares of the company’s stock after purchasing an additional 7,377 shares during the quarter. […]
Country Club Bank GFN increased its holdings in shares of Vanguard Short-Term Bond ETF (NYSEARCA:BSV – Free Report) by 9.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 31,428 shares of the company’s stock after purchasing an additional 2,769 shares […]